25(OH)D、IL-6、IGF-1在2型糖尿病合并骨质疏松症患者血浆中的水平被引量：17

Content of 25(OH)D,IL-6,IGF-1 in patient with Type 2 Diabetes Mellitus complicating Osteoporosis

导出

摘要目的通过观察2型糖尿病(T2DM)合并骨质疏松患者血浆25羟维生素D[25(OH)D]、白细胞介素-6(IL-6)、胰岛素样生长因子(IGF-1)、血脂及胰岛素抵抗(IR)水平,探讨其相互之间的关系。方法将研究对象分为T2DM组120例、T2DM合并骨质疏松症(OS)组(T2DM+OS组)110例,糖耐量正常者(NGT组)115例,空腹抽血测定25(OH)D、IL-6、胰岛素样生长因子(IGF-1)、糖化血红蛋白(HbA1c)、胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDLC),并计算稳态模型胰岛素抵抗指数(HOMA-IR)进行比较分析。结果 T2DM组25(OH)D、IGF-1、HDL-C低于NGT组,而IL-6、HbA1c,TC,TG,LDL-C、HOMA-IR均高于NGT组,差异有统计学意义(P<0.05);T2DM+OS组25(OH)D、IGF-1、HDL-C低于NGT组,而IL-6、HbA1c,TC,TG,LDL-C、HOMA-IR均高于NGT组,差异有统计学意义(P<0.05);T2DM+OS组25(OH)D、IGF-1低于T2DM组,IL-6均高于T2DM组,差异有统计学意义(P<0.05),而HDL-C、HbA1c,TC,TG,LDL-C、HOMA-IR比较,差异无统计学意义(P>0.05)。结论血浆25(OH)D、IGF-1水平降低及IL-6水平升高可能是T2DM合并骨质疏松的高危因素之一。 Objective To observe the level of 25-hydroxy vitamin D[25（OH）D],Interleukin,6 （IL-6）,Insulin-Like Growth Factor-l（IGF-1） ,blood lipid and insulin resistance（IR） in patients with type 2 diabetes mellitus（T2MD） and Osteoporosis. To in- vestigate the relationship of 25（OH）D3 with blood lipid and IR. Methods 120 patients with newly diagnosed T2DM group,ll0 pa- tients with type Z diabetes mellitus complicating Osteoporosis（T2DM ＋ os group）, 115 individuals with normal glucose tolerance （NGT group, as control） were enrolled. Fasting 25 （OH） I）, IL-6, IGF-1, HbA1 c, total cholesterol（TC）, triglyeeride（TG）, low densi- ty lipoprotein（LDL-C）,high density lipoprotein cholesterol（HDL-C） were determined. To compute HOMA-IR and to compare a- nalysis. Results The levels of 25（OH）D,IGF-1, HDL-C were more declined in T2DM group than those in NGT group （P〈0.05）. The levels of IL-6, HbAlc,TC, TG, LDL-C, HOMA-IR were significantly higher in T2DM group than those in NGT group（P〈 0.05）. The levels of 25（OH）D,IGF-1, HDL-C were more decl^ned in T2DM ＋os group than those in NGT group （P〈0.05）. The levels of IL-6, HbAlc, TC,TG,LDL-C, HOMA-IR were significantly higher in T2DM -}- os group than those in NGT group（P〈 0.05）. The levels of 25（OH）D,IGF＇l were more declined in T2DM q-OS group than those in T2DM group （P〈0.05）. The levels of IL-6 were significantly higher in T2DM -kOS group than those in T2DM group（P〈0.05）;the levels of HDL-C, HbAlc, TC, TG,LDL：C,HOMA-IR have no difference comparing T2DM ＋OS group and T2DM group（P〉0.05）, Conclusion The low levels of 25（OH）D,IGF-1 and high levels of IL-6 is a high risk of type 2 diabetes metlitus complicating osteoporosis.

作者阳琰高琳李庆钰晏永慧李显文陈其荣

机构地区合肥医学院附属医院内分泌科合肥医学院临床技能实验室

出处《重庆医学》 CAS 北大核心 2015年第21期2898-2900,共3页 Chongqing medicine

基金国家自然科学基金资助项目(81460168) 贵州省科学技术基金资助项目[黔科合J字LKZ(2013)19号] 合肥医学院博士启动基金资助项目[(2012)F-574] 贵州省优秀科技教育人才省长专项资金项目[黔省专合字(2008)110号] 贵州省科技合作项目[黔科合区域合(2010)7004号]

关键词白细胞介素6 胰岛素样生长因子Ⅰ 糖尿病 2型骨质疏松 25羟维生素D interleukin-6 insulin-like growth factor I diabetes mellitus, type 2 osteoporosis 25-hydroxy vitamin D

分类号 R587.2 [医药卫生—内分泌] R580 [医药卫生—内分泌]

引文网络
相关文献

参考文献14

1Issa C, Zantout MS, Azar ST. Osteoporosis in men withdiabetes mellitus[J]:l Osteoporos, 2011,2011 : 651867.
2Shpakov AO. The role of alterations in the brain signaling systems regulated by insulin, IGF-1 and leptin in the tran- sition of impaired glucose tolerance to overt type 2 diabe- tes mellitus[J]. Tsitologiia, 2014,56 (11) : 789-799.
3Palomer X, Gonzdlez-Clemente JM, Blanco-Vaca F, et al. Role o'f vitamin D in the pathogenesis of type 2 diabetes mellitus[J]. Diabetes Obes Metab,2008,10(3) : 185-197.
4E1 Lithy A, Abdella RM, E1-Faissal YM, et al. The rela- tionship between low maternal serum vitamin D levels and glycemic control in gestational diabetes assessed by HbAlc levels:an observational cross-sectional study[J]. BMC Pregnancy Childbirth, 2014,14 (4) : 362.
5Ford ES, Ajani UA, MeGuire LC, et al. Concentrations o serum vitamin D and the metabolic syndrome among US adults[-J-]. Diabetes Care,2005,28(5) :1228-1230.
6马远方,高桦,邱明才.2型糖尿病患者病程长短与骨密度和骨代谢指标关系的研究[J].中国慢性病预防与控制,2011,19(1):60-62. 被引量：8
7Kostoglou-Athanassiou I, Athanassiou P9 Gkountouvas A, et al. Vitamin D and glyeemie control in diabetes mellitus type 2 [J]. Ther Adv Endocrinol Metab,2013,4(4) :122-128.
8Cimbek A,Girsoy G,Kirnap NG,et al. Relation of obesi- ty with serum 25 hydroxy vitamin D3 levels in type 2 dia- betic patients [J]. J Res Med Sei, 2012, 17 ( 12 ) : 1119- 1123.
9Hossein-nezhad A, Holiek MF. Vitamin D for health., a global perspective[J]. Mayo Clin Proe, 2013,88 (7) ; 720- 755.
10Nasri H, Behradmanesh S, Maghsoudi AR, et al. Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus a randomized double blind clinical trial [J]. J Renal Inj Prev, 2013,3(1) , 31-34.

二级参考文献27

1罗静聪,伍援朝,李双庆.老年2型糖尿病患者骨密度变化及影响因素[J].现代预防医学,2004,31(2):175-176. 被引量：11
2冯晓丽,孟萍,袁林贵,高明发,黄姝.男性2型糖尿病合并骨质疏松患者骨生化指标改变[J].重庆医学,2005,34(1):42-43. 被引量：9
3黄国良,张莹.糖尿病性骨质疏松的评价与对策[J].实用糖尿病杂志,2006,2(4):4-6. 被引量：53
4朱翔,章秋.糖尿病性骨质疏松及其影响因素[J].实用糖尿病杂志,2006,2(4):6-8. 被引量：33
5Heap J ,Murray MA,Miller SC, et al. Alterations in bone characteristics associated with glycemic control in adolescents with typel diabetes mellitus[J]. J Pediatr, 2004, 144: 56-62.
6Yamamoto M, Yamaguchi T, Yamauchi M, et al. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes [J].Clin Endocrinol Metab, 2008, 93: 1013-1019.
7Sugden JA, Davies JI, Witham MD et al. Vitamin D improves endothelial function in patients with Types 2 diabetes mellitus and low vitamin Dlevels[J].Diabet Med, 2008,25:320-325.
8Mass D ,Jochen A,Lalande B.Age-related changes in male gonadal function:implication for therapy[J].Drugs Aging,1997,11:45-60.
9Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 2 diabetes-a meta-analysis [J]. Osteoporos Int, 2007,18:427 -444.
10de Liefde II,van der Klift M, de Laet CE, et al. One mineral density and fracture risk in type-2 diabetes mellitus:The Rotterdam study [J]. Osteoporosis Int,2005,16:1713-1720.